Published in Neuroscience on January 01, 2005
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry (2009) 1.64
Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry (2010) 1.30
Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets (2013) 1.26
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 1.23
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm (Vienna) (2008) 1.10
GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease. Front Cell Neurosci (2014) 0.98
Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics (2011) 0.98
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry (2016) 0.96
Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.92
Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology (Berl) (2007) 0.92
Toward an anti-inflammatory strategy for depression. Front Behav Neurosci (2011) 0.90
Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats. Mol Psychiatry (2014) 0.87
Neuropathological changes in the nucleus basalis in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.86
Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology (2011) 0.86
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology (2014) 0.86
Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. Mol Psychiatry (2013) 0.85
Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study. Med Mol Morphol (2011) 0.82
Cytokines and the neurodevelopmental basis of mental illness. Front Neurosci (2013) 0.81
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue. Front Cell Neurosci (2015) 0.80
Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Interv Psychiatry (2008) 0.80
Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro. Physiol Genomics (2012) 0.80
Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. Schizophr Res (2014) 0.80
Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology. Front Psychiatry (2015) 0.79
Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl Psychiatry (2016) 0.78
Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats. J Neural Transm (Vienna) (2007) 0.78
Modeling psychiatric disorders: from genomic findings to cellular phenotypes. Mol Psychiatry (2016) 0.78
ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia. Front Cell Neurosci (2015) 0.76
Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2008) 0.76
Psychiatric disorders biochemical pathways unraveled by human brain proteomics. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model. Transl Psychiatry (2015) 0.75
Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia. BMC Med Genomics (2016) 0.75
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry (2002) 2.43
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol (2004) 2.18
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 2.12
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry (1993) 1.78
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry (2010) 1.77
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry (1993) 1.75
Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience (2003) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry (2004) 1.62
Motivational aspects of deliberate self-poisoning in adolescents. Br J Psychiatry (1982) 1.62
Adolescents who take overdoses: their characteristics, problems and contacts with helping agencies. Br J Psychiatry (1982) 1.59
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry (2012) 1.58
Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology (1993) 1.58
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry (1993) 1.52
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns (2006) 1.48
Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol (1982) 1.48
Choline acetyltransferase in schizophrenia. Am J Psychiatry (1993) 1.47
Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex (2006) 1.46
Monoclonal antibodies to study the brain in schizophrenia. Brain Res (1989) 1.45
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. Am J Hematol (1991) 1.43
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience (2004) 1.40
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol (2000) 1.40
Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man. Eur J Cardiol (1980) 1.36
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Stenoses of vascular anastomoses after hepatic transplantation: treatment with balloon angioplasty. AJR Am J Roentgenol (1991) 1.34
Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts. J Eukaryot Microbiol (2000) 1.32
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
Transcriptome analysis of male-female differences in prefrontal cortical development. Mol Psychiatry (2009) 1.28
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2005) 1.27
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry (2003) 1.23
Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry (2011) 1.22
Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience (2006) 1.19
The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci (1991) 1.17
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience (1999) 1.11
Cerebellar pathology in schizophrenia: a controlled postmortem study. Am J Psychiatry (1980) 1.11
Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation (1994) 1.11
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Fam Pract (2001) 1.11
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut (2007) 1.11
A postmortem quantitative study of iron in the globus pallidus of schizophrenic patients. Biol Psychiatry (1990) 1.10
Speaking, thinking, and blinking. Psychiatry Res (1981) 1.09
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J (2003) 1.09
Aspirin: A paradoxical effect on bleeding-time. Lancet (1978) 1.08
Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci (2002) 1.08
Plasma prolactin concentrations and psychopathology in chronic schizophrenia. Arch Gen Psychiatry (1982) 1.08
BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci (2001) 1.07
Hyperacute rejection in liver transplantation: a case report. Transplant Proc (1989) 1.07
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am J Trop Med Hyg (2004) 1.05
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience (2010) 1.05
A modified larval migration assay for detection of resistance to macrocyclic lactones in Haemonchus contortus, and drug screening with Trichostrongylidae parasites. Vet Parasitol (2006) 1.04
Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol (2008) 1.04
Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development. Mol Psychiatry (2010) 1.03
Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm (Vienna) (2004) 1.01
Neuropathology of bipolar disorder. Biol Psychiatry (2000) 1.00
Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit. J Hosp Infect (1991) 0.99
Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Trop Med Int Health (2012) 0.99
Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. Br Med J (1980) 0.99
Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol (1992) 0.98
The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. Arch Gen Psychiatry (1990) 0.98
Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis (1999) 0.97
Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects. Mol Psychiatry (2002) 0.97
Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology (1992) 0.97
Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neuroscience (2005) 0.96
Is there cognitive decline in schizophrenia? A cross-sectional study. Br J Psychiatry (1994) 0.95
Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation. Transl Psychiatry (2012) 0.95
Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95
Drug effect on blink rates in rhesus monkeys: preliminary studies. Biol Psychiatry (1981) 0.95
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc (1989) 0.95
Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia. Schizophr Res (2001) 0.95
The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience (1994) 0.94
Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology (1993) 0.93
Genetic variation in DNMT3B and increased global DNA methylation is associated with suicide attempts in psychiatric patients. Genes Brain Behav (2012) 0.93
Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry (1999) 0.91
Liver transplantation in adults coinfected with HIV. Transplantation (2001) 0.91
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry (1997) 0.91
A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. Brain Res Bull (2001) 0.91
A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. Br J Clin Pharmacol (1984) 0.91